血清胃蛋白酶原、胃泌素-17联合内镜优化筛查方案在早期胃癌中的应用

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo investigate the effect of pepsinogen (PG)and gastrin-17 (G-17)combined with endoscopic screening in the diagnosis of early gastric cancer.MethodsFrom January 2015 to December 2015,145 outpatient and inpatient 145 subjects because of upper abdominal pain,belching and other symptoms of upper digestive tract in our hospital were selected and divided into the normal group(n=30),the atrophic gastritis group(n=28),the gastric ulcer group (n=25),the early gastric cancer group (n=32)and the advanced gastric cancer group (n=30)according to endoscopic biopsy and histopathological examination.The levels of serum PGⅠ,PGⅡand G-17 were detected,and their value in the diagnosis of gastric cancer was discussed.ResultsThe levels of PGⅠand PGR in the atrophic gastritis group,the early gastric cancer group and the advanced gastric cancer group was lower than that in the normal group,the G-17 level was higher than in the normal group(P＜0.05).The levels of PGⅠand PGR in the atrophic gastritis group and the gastric ulcer group was higher than that in the early gastric cancer group,the levels of PGⅠand PGR in the advanced gastric cancer group was lower than that in the early gastric cancer group,the level of G-17 in the advanced gastric cancer group was higher than that in the early gastric cancer group (P＜0.05).The AUC of PGⅠ,PGⅡ,PGR,G-17 and joint detection in the gastric cancer group and the non-gastric cancer group was significantly higher than that in the control group(AUC= 0.5)(P＜0.05).Four groups of joint detection of AUC was higher than that in the single detection,the specificity and sensitivity of joint detection was higher than that in the non-gastric cancer group.ConclusionThe PGⅠ,G-17 combined with endoscopic screening is help to improve the early diagnosis rate of gastric cancer,it is worthy of clinical promotion and application.

Key words： Gastric cancer Serum pepsinogen Gastrin-17 Endoscope

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XIE Jun-feng
	WU Xiao-juan
	XIE Ning-sheng
	TANG Jian-hua

Cite this article:

XIE Jun-feng,WU Xiao-juan,XIE Ning-sheng, et al. Application of serum pepsinogen and gastrin-17 combined with endoscopic screening protocol in early gastric cancer[J]. 中国当代医药, 2017, 24(13): 81-83.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I13/81

[5]	刘文佳，毛秋卉，张学俭，等.血清胃蛋白酶原和胃泌素-17筛选胃癌及癌前病变有效性[J].中华实用诊断与治疗杂志，2015，29（9）：885-887.
[6]	黄蔚，蔡美珠，吴瑶，等.血清胃蛋白酶原和胃泌素-17联合检测在老年胃癌及萎缩性胃炎中的临床意义[J].中国医药指南，2008，6（2）：134-136.
[7]	李林，张立新，艾冬琴，等.血清胃蛋白酶原和胃泌素-17检测在胃癌筛查中的应用[J].海南医学，2015，25（22）：3335-3337.
[8]	赵峰，苗怡然，苗森，等.联合检测外周血胃泌素17及胸苷激酶1水平对胃癌的临床诊断价值分析[J].胃肠病学和肝病学杂志，2016，25（11）：1241-1243.
[1]	司望利，王田芳，庄坤，等.放大内镜结合窄带成像技术在早期胃癌诊断中的应用[J].临床医学研究与实践，2016，1 （24）：192-194.
[2]	吴冠楠，姚学权，刘福坤.血清胃蛋白酶原对早期胃癌检测的研究进展[J].检验医学与临床，2015，12（14）：2126-2128.
[3]	吴志成，陈娟，何敏，等.血清胃蛋白酶原对胃癌早期诊断的应用研究[J].国际检验医学杂志，2010，31（8）：786-787.
[4]	黄容旺，范文伟，李国斌，等.血清胃蛋白酶原与再生基因Ⅳ联合检验对胃癌早期诊断的应用价值[J].重庆医学，2014，43（14）：1755-1757.
[9]	毛秋卉，刘文佳，张学俭，等.血清胃蛋白酶原和胃泌素-17在胃癌筛选中的作用[J].国际消化病杂志，2012，32（2）：85-87.
[10]	马颖杰，曹邦伟，李琴，等.胃癌患者及其化疗后胃蛋自酶原与胃泌素变化的临床意义[J].临床和实验医学杂志，2014，13（3）：186-189.
[11]	张志镒，王贵齐，吴正奇，等.血清胃蛋自酶原检测在胃癌及其癌前病变筛查中的价值[J].世界华人消化杂志，2011，19（14）：1511-1514.
[12]	高海燕，于秀艳，汪杰.血清胃蛋白酶原（PGI）测定对胃癌的诊断意义[J].中国实验诊断学，2009，13（9）：1250.
[13]	胡仁静，严子禾，沈洪远.血清胃蛋自酶原在胃癌诊断中的价值[J].中国实验诊断学，2010，14（10）：1650-1651.
[14]	黄语嫣，陈卫昌，高楠，等.血清胃蛋自酶原Ⅰ、Ⅱ在胃癌及癌前病变诊断中的价值[J].中华内科杂志，2013，52（4）：332-333.
[15]	张玲霞，庄坤，张沥，等.血清胃泌素-17、胃蛋自酶原及幽门螺杆菌IgG抗体与萎缩性胃炎及胃癌的关系研究[J].检验医学与临床，2014，11（8）：1076-1078.